Priser
Platform
Blog
Om os
Download
OTO
Otofarma
Borsa Italiana
0

Om

Otofarma S.p.A. is a healthcare company specializing in the design, production, and marketing of custom-made hearing aids and related accessories. Its primary focus is on delivering tailored hearing solutions via a vertically integrated model that encompasses both manufacturing and distribution. The company distinguishes itself through the integration of tele-audiology services, remote diagnostics, and audiometric consultations, enhancing access and convenience for patients. Otofarma’s products are distributed across Italy through an extensive network of over 4,000 affiliated pharmacies, as well as direct sales channels, medical centers, clinics, and nursing homes, ensuring broad reach within primary and specialist care environments. With a portfolio of instrumental IT patents and a strategy centered on technological innovation, Otofarma addresses diverse audiological needs and supports the advancement of telemedicine in hearing care. Its significant presence in the medical devices sector positions it as a leading player in Italy’s hearing aid market, demonstrating strong growth and a commitment to accessibility, quality, and efficient service delivery.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I OTOFARMA MED ENDAVU: Køb Otofarma ($OTO) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Otofarma, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerOTO
Land
Italien
Hjemmesideotofarmaspa.com
SektorSundhed
IndustriMedicinsk udstyr

Analytikerskøn

Baseret på 1 analytiker

Stærkt købKøbHoldSælgStærkt sælg
0%100%0%0%0%